Latest Insider Transactions at Healthstream Inc (HSTM)
This section provides a real-time view of insider transactions for Healthstream Inc (HSTM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HEALTHSTREAM INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HEALTHSTREAM INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Michael Manning Collier Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+3.06%
|
-
|
|
Sep 12
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
250
+0.51%
|
$5,500
$22.5 P/Share
|
|
Sep 12
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
417
+0.33%
|
$9,174
$22.5 P/Share
|
|
Sep 12
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
267
+0.14%
|
$5,874
$22.5 P/Share
|
|
Jul 29
2022
|
Jeffrey L Mclaren Director |
SELL
Open market or private sale
|
Direct |
5,000
-27.68%
|
$120,000
$24.17 P/Share
|
|
Jun 24
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
236
+0.19%
|
$4,956
$21.22 P/Share
|
|
Jun 24
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
236
+0.49%
|
$4,956
$21.22 P/Share
|
|
Jun 24
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
236
+0.12%
|
$4,956
$21.22 P/Share
|
|
Jun 10
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
497
+0.25%
|
$9,940
$20.12 P/Share
|
|
Jun 10
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
528
+0.42%
|
$10,560
$20.12 P/Share
|
|
Jun 10
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
528
+1.09%
|
$10,560
$20.12 P/Share
|
|
Mar 17
2022
|
Frank Gordon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+1.34%
|
-
|
|
Mar 17
2022
|
Thompson Dent Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+2.06%
|
-
|
|
Mar 17
2022
|
Linda Rebrovick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+5.34%
|
-
|
|
Mar 17
2022
|
Michael D Shmerling Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+2.08%
|
-
|
|
Mar 17
2022
|
William Stead Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+6.98%
|
-
|
|
Mar 17
2022
|
Tate Deborah Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+10.65%
|
-
|
|
Mar 17
2022
|
Robert A Frist Jr CEO and Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
1,291
-0.03%
|
$24,529
$19.94 P/Share
|
|
Mar 17
2022
|
Robert A Frist Jr CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
5,298
+0.11%
|
-
|
|
Mar 17
2022
|
Trisha L Coady Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-6.42%
|
$18,487
$19.94 P/Share
|
|
Mar 17
2022
|
Trisha L Coady Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,072
+21.18%
|
-
|
|
Mar 17
2022
|
Michael Manning Collier Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,241
-5.11%
|
$23,579
$19.94 P/Share
|
|
Mar 17
2022
|
Michael Manning Collier Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,186
+17.6%
|
-
|
|
Mar 17
2022
|
Jeff Cunningham Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,113
-7.67%
|
$21,147
$19.94 P/Share
|
|
Mar 17
2022
|
Jeff Cunningham Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,663
+24.32%
|
-
|
|
Mar 17
2022
|
Scott Fenstermacher Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,079
-15.4%
|
$20,501
$19.94 P/Share
|
|
Mar 17
2022
|
Scott Fenstermacher Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,048
+30.31%
|
-
|
|
Mar 17
2022
|
Michael Scott Mc Quigg Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-9.12%
|
$14,079
$19.94 P/Share
|
|
Mar 17
2022
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,058
+27.34%
|
-
|
|
Mar 17
2022
|
Kevin P O'Hara Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-11.23%
|
$3,496
$19.94 P/Share
|
|
Mar 17
2022
|
Kevin P O'Hara Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
782
+32.3%
|
-
|
|
Mar 17
2022
|
J Edward Pearson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,421
-1.79%
|
$64,999
$19.94 P/Share
|
|
Mar 17
2022
|
J Edward Pearson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,048
+6.83%
|
-
|
|
Mar 17
2022
|
Scott Alexander Roberts CFO and SVP |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-6.44%
|
$12,578
$19.94 P/Share
|
|
Mar 17
2022
|
Scott Alexander Roberts CFO and SVP |
BUY
Exercise of conversion of derivative security
|
Direct |
2,694
+20.76%
|
-
|
|
Mar 17
2022
|
Michael Sousa Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,083
-11.73%
|
$115,577
$19.94 P/Share
|
|
Mar 17
2022
|
Michael Sousa Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
21,048
+28.87%
|
-
|
|
Mar 17
2022
|
Jeffrey L Mclaren Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,675
+12.9%
|
-
|
|
Mar 10
2022
|
Michael D Shmerling Director |
BUY
Grant, award, or other acquisition
|
Direct |
466
+0.38%
|
$9,320
$20.12 P/Share
|
|
Mar 10
2022
|
Linda Rebrovick Director |
BUY
Grant, award, or other acquisition
|
Direct |
280
+0.62%
|
$5,600
$20.12 P/Share
|
|
Mar 10
2022
|
Frank Gordon Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.15%
|
$5,960
$20.12 P/Share
|
|
Mar 08
2022
|
Tate Deborah Taylor Director |
SELL
Bona fide gift
|
Direct |
200
-1.0%
|
-
|
|
Mar 07
2022
|
Tate Deborah Taylor Director |
SELL
Bona fide gift
|
Direct |
400
-1.96%
|
-
|
|
Feb 24
2022
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Open market or private purchase
|
Direct |
500
+8.98%
|
$9,500
$19.12 P/Share
|
|
Jan 31
2022
|
Scott Fenstermacher Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
127
-3.11%
|
$3,048
$24.45 P/Share
|
|
Jan 31
2022
|
Scott Fenstermacher Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
356
+8.01%
|
-
|
|
Jan 31
2022
|
Michael Scott Mc Quigg Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
579
-11.25%
|
$13,896
$24.45 P/Share
|
|
Jan 31
2022
|
Michael Scott Mc Quigg Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,950
+27.47%
|
-
|
|
Jan 08
2022
|
Kevin P O'Hara Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-29.7%
|
$9,050
$25.62 P/Share
|
|
Jan 08
2022
|
Kevin P O'Hara Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,219
+50.0%
|
-
|